pH-sensitive microemulsion-based gels for removal of colonic ammonia: A novel preventative oral preparation for hepatic encephalopathy in rats

• Published in: Molecular medicine reports Vol. 11; no. 5; pp. 3925 - 3933
• Main Authors: ZHANG, CHUN-LE, DUAN, ZHI-JUN, TIAN, GE, TIAN, YAN, HE, GAO-HONG, BIAN, TENG-FEI, JIN, XUE, SUN, XIAO-YU, LIU, ZHEN, CHANG, QING-YONG
• Format: Journal Article
• Language: English
• Published: Greece D.A. Spandidos 01.05.2015; Spandidos Publications; Spandidos Publications UK Ltd
• Subjects: Acetic acid; Alanine Transaminase - metabolism; Ammonia; Ammonia - adverse effects; Ammonia - blood; Ammonia - metabolism; Animal models; Animals; Bacteria; Bilirubin - metabolism; Body Weight; Care and treatment; colonic ammonia removal; Diagnosis; Disease Models, Animal; Drug dosages; EEG; Electroencephalography; Emulsions - administration & dosage; Enzymes; Gastrointestinal tract; Gels; Health aspects; Hepatic encephalopathy; Hepatic Encephalopathy - diagnosis; Hepatic Encephalopathy - etiology; Hepatic Encephalopathy - mortality; Hepatic Encephalopathy - therapy; Hydrogen-Ion Concentration; Intestine; Intestines - metabolism; Lactulose; Liver - metabolism; Liver - pathology; Liver diseases; Male; Metabolism; Metabolites; microemulsion-based gel; pH effects; pH-sensitive gel; preventative oral preparation; Prevention; Proteins; Rats; Rodents; Sleep; Sodium; Studies; Surfactants; Thioacetamide; China
• ISSN: 1791-2997; 1791-3004
• DOI: 10.3892/mmr.2015.3201

Microemulsions with limited stability in mimetic gastrointestinal environments have previously demonstrated potential for the effective removal of ammonia from artificial colonic fluid. Specialized pH-sensitive microemulsion-based gels for the removal of colonic ammonia (MBG-RCA), however, possess relative stability in the gastrointestinal (GI) tract of normal rats, indicating potential use in in vivo applications. An investigation of the effects of oral MBG-RCA was conducted in order to evaluate the reduction of intestinal ammonia and the prevention of hepatic encephalopathy (HE) in rat models. Eighty rats were allocated into eight 4-day treatment groups: The HE model (intraperitoneal injection of thioacetamide) group; the high-, medium- and low-dose MBG-RCA therapeutic groups (15, 10 and 5 ml/kg MBG-RCA, respectively); and the normal, blank, lactulose and acetic acid control groups, each of which received daily treatment administration. Oral MBG-RCA effects were identified using behavioral monitoring observed by an infrared night vision supervisory control system, electroencephalograms, blood ammonia levels, intestinal ammonia levels, liver functionality and pathological observation. High- and medium-dose oral administrations of MBG-RCA significantly decreased the blood and intestinal ammonia levels (P<0.05), improved liver functionality and reduced the clinical manifestations of HE in rats. MBG-RCA demonstrated high clearance of rat colonic ammonia while maintaining sufficient stability in the GI tract, indicating the potential for the development of new clinically relevant oral preparations for the prevention of HE. Additionally, such preparations are advantageous in that ammonia is eliminated without the production of potentially harmful metabolic byproducts.